Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1 (Stem Cell Research and Therapy (2018) 9 (15) DOI: 10.1186/s13287-017-0759-z)

Research output: Contribution to journalComment/debate

Abstract

The original article [1] contains a number of small errors which the authors would like to clarify: In Fig. 1a of the original article, FGF10 concentration should be 50 ng/ml as correctly stated in the Methods section instead of 100 ?g/ml. 2) Also in Fig. 1a of the original article, Activin A and EGF concentrations should both be 100 ng/ml as correctly stated in the Methods section instead of 100 ?g/ml. 3) In the Methods section under the sub-heading Differentiation of human pluripotent stem cells into pancreatic progenitor", the term, 50 ng/ml hFGF10 should be omitted from the following sentence: At the end of stage 3, media were changed to DMEM supplemented with 1% vol/vol B27, 0.25 mM vitamin C, 50 ng/ml hFGF10, 50 ng/ml hNOGGIN, 100 ng/ml EGF, and 10 mM nicotinamide (Sigma, USA) for 4 days of stage 4 treatment for each protocol (Fig. 1a)." FGF10 was only added during stages 2 & 3 of differentiation as correctly depicted in Fig. 1a. The corrected version of Fig. 1a can be viewed ahead. (Figure Presented).

Original languageEnglish
Article number262
JournalStem Cell Research and Therapy
Volume9
Issue number1
DOIs
Publication statusPublished - 7 Oct 2018

    Fingerprint

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Cell Biology

Cite this